Taurine

許可證數量: 1

2-AMINO-6-CHLORO-4-NITROPHENOL

許可證數量: 628

2-METHYL-5-HYDROXYETHYLAMINOPHENOL

許可證數量: 1354

2,4-DIAMINOPHENOXYETHANOL SULFATE

許可證數量: 95

4-NITRO-O-PHENYLENEDIAMINE

許可證數量: 237

Acalabrutinib Maleate

許可證數量: 1

HYDROXYBENZOMORPHOLINE

許可證數量: 138

ISOTRETINOIN

許可證數量: 15

Omega-3 acid ethy1 esters 90 content: – EPA and DHA ethyl esters: minimum 80.0% and maximum 88.2%, with minimum 43.0% and maximum 49.5% of EPA ethyl esters and minimum 34.7% and maximum 40.3% of DHA ethyl esters; – total om

許可證數量: 1

PROPRANOLOL HCL

許可證數量: 147

鵝不食草

許可證數量: 10

EPHEDRINE HCL (EQ TO EPHEDRINE HYDROCHLORIDE)

許可證數量: 203

Ezetimibe Monohydrate (Form B)

許可證數量: 1

FLUVOXAMINE MALEATE

許可證數量: 10

Sulfamethoxazole Sodium contains not less than 98.0% and not more than 100.5% of C10H10N3O3S, calculated on the anhydrous basis.

許可證數量: 1

CIMETIDINE

許可證數量: 313

Dried Aluminum Hydroxide Gel Fine Granules contain not less than 47.0% of aluminum oxide (A1203:101.96).

許可證數量: 1

製何首烏

許可證數量: 68

Antimony Potassium Tartrate contains not less than 99.0% and not more than 103.0% of C8H4K2O12SB2・3H2O, calculated on the anhydrous basis.

許可證數量: 1

Azilsartan Kamedoxomil (Form-I) (C30H23KN4O8) contains NLT 97.0% and NMT 102.0% w/w on anhydrous basis.

許可證數量: 1

HYDROXOCOBALAMIN ACETATE

許可證數量: 50

Mirikizumab

許可證數量: 2

LETROZOLE

許可證數量: 12

Sennosides 60% NLT 90.0% and NMT 110.0% of the labeled amount of sennosides The labeled amount is NLT 60.0% (w/w), calculated on the dried basis..

許可證數量: 1

苦參子

許可證數量: 11

薤白

許可證數量: 22

路路通

許可證數量: 11

AVOBENZONE

許可證數量: 178

OCTISALATE

許可證數量: 132

Omidenepag isopropyl

許可證數量: 2

EVOCALCET

許可證數量: 2

INSULIN HUMAN

許可證數量: 30

DAPTOMYCIN

許可證數量: 3

20% CHLORHEXIDINE GLUCONATE SOLUTION

許可證數量: 31

AMMONIUM PERSULFATE

許可證數量: 245

FLUTICASONE FUROATE

許可證數量: 2

POLYMYXIN B SULFATE

許可證數量: 60

POTASSIUM PERSULFATE

許可證數量: 281

SODIUM PERSULFATE

許可證數量: 135

以上生藥製成浸膏4.8g

許可證數量: 3

以上生藥製成浸膏7g

許可證數量: 5

皂角

許可證數量: 38

BOTULINUM TOXIN TYPE A

許可證數量: 6

Fentanyl

許可證數量: 12

HEXOPRENALINE SULFATE

許可證數量: 11

Imipenem and Cilastatin for injection is a sterile mixture of Imipenem, Cilastatin Sodium, and Sodium Bicarbonate. It contains not less than 90.0 percent and not more than 115.0 percent of the labeled amounts of Imipenem(C12H

許可證數量: 1

以上生藥製成浸膏9.5g

許可證數量: 3

6-HYDROXYINDOLE

許可證數量: 348

Hydroxyethyl-3,4-methylenedioxyaniline HCl

許可證數量: 28

以上生藥製成浸膏0.45g

許可證數量: 5